Genelux (GNLX) News Today $2.49 +0.01 (+0.40%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Genelux Corp’s Strategic Advances in Cancer Trials Position GNLX as a Promising InvestmentNovember 17, 2024 | markets.businessinsider.comThese 2 “Strong Buy” Penny Stocks Are Set to Triple (or more), Say AnalystsNovember 15, 2024 | finance.yahoo.comGenelux (NASDAQ:GNLX) Price Target Cut to $30.00 by Analysts at HC WainwrightHC Wainwright cut their price target on Genelux from $32.00 to $30.00 and set a "buy" rating on the stock in a research report on Friday.November 15, 2024 | marketbeat.comGenelux Corporation Reports Third Quarter 2024 Financial Results and Provides General Business UpdatesNovember 14, 2024 | markets.businessinsider.comGenelux Corp. Releases New Corporate PresentationNovember 9, 2024 | markets.businessinsider.comGenelux Corporation to Participate in Fireside Chat at the Guggenheim Inaugural Healthcare Innovation ConferenceNovember 6, 2024 | globenewswire.comIndividual investors who hold 56% of Genelux Corporation (NASDAQ:GNLX) gained 34%, institutions profited as wellOctober 31, 2024 | finance.yahoo.comGenelux initiated with a Buy at GuggenheimOctober 30, 2024 | markets.businessinsider.comGuggenheim Initiates Coverage of Genelux (GNLX) with Buy RecommendationOctober 30, 2024 | msn.comGenelux Co. (NASDAQ:GNLX) Receives Consensus Rating of "Buy" from BrokeragesShares of Genelux Co. (NASDAQ:GNLX - Get Free Report) have been given an average rating of "Buy" by the five analysts that are covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the coOctober 29, 2024 | marketbeat.comGenelux (NASDAQ:GNLX) Now Covered by GuggenheimGuggenheim began coverage on shares of Genelux in a research note on Tuesday. They issued a "buy" rating and a $8.00 target price for the company.October 29, 2024 | marketbeat.comHighbridge Capital Management LLC Acquires Significant Stake in Genelux CorpOctober 25, 2024 | finance.yahoo.comPromising Growth Potential and Clinical Advancements Drive Buy Rating for Genelux Corp.October 25, 2024 | markets.businessinsider.comGenelux doses first subject in Phase II trial of NSCLC treatmentOctober 23, 2024 | finance.yahoo.comGenelux:1st patient dosed in VIRO-25 trial with Olvi-Vec in NSCLCOctober 23, 2024 | markets.businessinsider.comGenelux (NASDAQ:GNLX) Stock Quotes, Forecast and News SummaryOctober 23, 2024 | benzinga.comGenelux Corporation Announces First Patient Dosed in Phase 2 Trial Evaluating Systemic Therapy with Olvi-Vec in Non-Small Cell Lung CancerOctober 22, 2024 | globenewswire.comGenelux Corporation to Participate in the 2024 Maxim Healthcare Virtual SummitOctober 9, 2024 | globenewswire.com900,000 Shares in Genelux Co. (NASDAQ:GNLX) Acquired by Armistice Capital LLCArmistice Capital LLC acquired a new stake in Genelux Co. (NASDAQ:GNLX - Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund acquired 900,000 shares of the company's stock, valued at approximately $1,755,September 27, 2024 | marketbeat.comHighbridge Capital Management LLC Invests $1.23 Million in Genelux Co. (NASDAQ:GNLX)Highbridge Capital Management LLC bought a new stake in Genelux Co. (NASDAQ:GNLX - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 631,307 shares of the company's stock, valued at approximaSeptember 19, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Short Interest UpdateGenelux Co. (NASDAQ:GNLX - Get Free Report) was the recipient of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 1,150,000 shares, a decline of 7.3% from the August 15th total of 1,240,000 shares. Currently, 4.2% of the shares of the company are short sold. Based on an average daily volume of 206,800 shares, the short-interest ratio is currently 5.6 days.September 18, 2024 | marketbeat.comGenelux corp insider sells over $170k in company stockSeptember 15, 2024 | investing.comAladar Szalay Sells 33,080 Shares of Genelux Co. (NASDAQ:GNLX) StockSeptember 14, 2024 | insidertrades.comAladar Szalay Sells 23,383 Shares of Genelux Co. (NASDAQ:GNLX) StockSeptember 12, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $63,134.10 in StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 23,383 shares of the company's stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $2.70, for a total value of $63,134.10. Following the completion of the sale, the insider now directly owns 716,438 shares in the company, valued at approximately $1,934,382.60. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Large shareholders that own 10% or more of a company's stock are required to disclose their transactions with the SEC.September 11, 2024 | marketbeat.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Aladar Szalay Sells 42,818 SharesSeptember 7, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 42,818 Shares of StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 42,818 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $2.09, for a total value of $89,489.62. Following the completion of the sale, the insider now directly owns 739,821 shares of the company's stock, valued at approximately $1,546,225.89. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Large shareholders that own more than 10% of a company's shares are required to disclose their transactions with the SEC.September 6, 2024 | marketbeat.comGenelux Corporation to Present at the H.C. Wainwright Global Investment ConferenceSeptember 3, 2024 | globenewswire.comAladar Szalay Sells 107,045 Shares of Genelux Co. (NASDAQ:GNLX) StockAugust 31, 2024 | insidertrades.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 107,045 Shares of StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 107,045 shares of the stock in a transaction on Thursday, August 29th. The stock was sold at an average price of $1.98, for a total value of $211,949.10. Following the completion of the transaction, the insider now directly owns 925,228 shares in the company, valued at $1,831,951.44. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.August 30, 2024 | marketbeat.comGenelux started at buy by Roth MKM ahead of Olvi-Vec readoutsAugust 30, 2024 | msn.comAnalysts Set Expectations for Genelux Co.'s Q3 2024 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Analysts at Roth Capital issued their Q3 2024 earnings estimates for Genelux in a research report issued to clients and investors on Tuesday, August 27th. Roth Capital analyst B. Paluch expects that the company will earn ($0.20) per share for the quarter.August 30, 2024 | marketbeat.comRoth MKM Initiates Coverage of Genelux (GNLX) with Buy RecommendationAugust 29, 2024 | msn.comGenelux Co. (NASDAQ:GNLX) Given Consensus Recommendation of "Buy" by BrokeragesShares of Genelux Co. (NASDAQ:GNLX - Get Free Report) have been given an average recommendation of "Buy" by the five ratings firms that are currently covering the company, Marketbeat.com reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price target amongAugust 29, 2024 | marketbeat.comGenelux (NASDAQ:GNLX) Rating Increased to Strong-Buy at Roth CapitalRoth Capital upgraded Genelux to a "strong-buy" rating in a research report on Tuesday.August 29, 2024 | marketbeat.comInsider Selling: Genelux Co. (NASDAQ:GNLX) Major Shareholder Sells 40,000 Shares of StockAugust 28, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Major Shareholder Sells $91,600.00 in StockGenelux Co. (NASDAQ:GNLX - Get Free Report) major shareholder Aladar Szalay sold 40,000 shares of Genelux stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $2.29, for a total transaction of $91,600.00. Following the completion of the sale, the insider now owns 1,099,821 shares of the company's stock, valued at approximately $2,518,590.09. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Large shareholders that own at least 10% of a company's shares are required to disclose their sales and purchases with the SEC.August 27, 2024 | marketbeat.comEquities Analysts Offer Predictions for Genelux Co.'s Q3 2024 Earnings (NASDAQ:GNLX)Genelux Co. (NASDAQ:GNLX - Free Report) - Stock analysts at Brookline Capital Management decreased their Q3 2024 EPS estimates for shares of Genelux in a research report issued to clients and investors on Wednesday, August 14th. Brookline Capital Management analyst K. Dolliver now expects that thAugust 19, 2024 | marketbeat.comShort Interest in Genelux Co. (NASDAQ:GNLX) Declines By 8.9%Genelux Co. (NASDAQ:GNLX - Get Free Report) was the recipient of a large decrease in short interest in July. As of July 31st, there was short interest totalling 1,230,000 shares, a decrease of 8.9% from the July 15th total of 1,350,000 shares. Based on an average trading volume of 282,700 shares, the short-interest ratio is currently 4.4 days. Approximately 4.6% of the shares of the company are short sold.August 18, 2024 | marketbeat.comIs Genelux (NASDAQ:GNLX) In A Good Position To Invest In Growth?August 17, 2024 | finance.yahoo.comGenelux Corporation Reports Second Quarter 2024 Financial Results and Provides General Business UpdatesAugust 14, 2024 | globenewswire.comGenelux Corporation (GNLX): A Strong Buy According to Hedge FundsAugust 13, 2024 | msn.comGenelux Corporation to Participate in Fireside Chat at BTIG’s Virtual Biotechnology Conference 2024July 30, 2024 | finance.yahoo.comGenelux Corporation to Participate in Fireside Chat at BTIG's Virtual Biotechnology Conference 2024July 30, 2024 | globenewswire.comGenelux Corp.July 19, 2024 | barrons.comGenelux Co. (NASDAQ:GNLX) Insider Caroline Jewett Sells 4,961 SharesJuly 10, 2024 | insidertrades.comGenelux Co. (NASDAQ:GNLX) Insider Sells $10,517.32 in StockGenelux Co. (NASDAQ:GNLX - Get Free Report) insider Caroline Jewett sold 4,961 shares of the business's stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $2.12, for a total value of $10,517.32. Following the sale, the insider now owns 16,174 shares in the company, valued at $34,288.88. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.July 8, 2024 | marketbeat.comWoodward Diversified Capital LLC Boosts Stock Holdings in Genelux Co. (NASDAQ:GNLX)Woodward Diversified Capital LLC increased its stake in Genelux Co. (NASDAQ:GNLX - Free Report) by 2,326.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,082,270 shares of the company's stock after buying an additionaJune 9, 2024 | marketbeat.comGenelux (NASDAQ:GNLX) Price Target Cut to $25.00 by Analysts at BenchmarkBenchmark dropped their price objective on Genelux from $30.00 to $25.00 and set a "speculative buy" rating for the company in a research note on Friday.May 31, 2024 | marketbeat.comWhy Genelux Corporation (GNLX) Shares Are Down 40%May 24, 2024 | msn.com Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address 2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad)The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] GNLX Media Mentions By Week GNLX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GNLX News Sentiment▼-0.560.46▲Average Medical News Sentiment GNLX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GNLX Articles This Week▼51▲GNLX Articles Average Week Get Genelux News Delivered to You Automatically Sign up to receive the latest news and ratings for GNLX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Kamada News Alpha Teknova News biote News COMPASS Pathways News AC Immune News Jasper Therapeutics News Design Therapeutics News Lyell Immunopharma News Sage Therapeutics News Kodiak Sciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GNLX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genelux Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genelux With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNLX Stock Alerts